These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6286040)

  • 21. Effects of noradrenergic agonists and antagonists on growth hormone secretion under gamma-hydroxybutyrate narco-analgesia in the rat.
    Schaub C; Bluet-Pajot MT; Mounier F; Segalen A; Duhault J
    Psychoneuroendocrinology; 1980; 5(2):139-46. PubMed ID: 6104836
    [No Abstract]   [Full Text] [Related]  

  • 22. Behavioral effects of direct- and indirect-acting dopaminergic agonists.
    Moore KE
    Adv Biochem Psychopharmacol; 1974; 12(0):403-14. PubMed ID: 4371765
    [No Abstract]   [Full Text] [Related]  

  • 23. Adenosine 3',5'-monophosphate content in rat caudate nucleus: demonstration of dopaminergic and adrenergic receptors.
    Forn J; Krueger BK; Greengard P
    Science; 1974 Dec; 186(4169):1118-20. PubMed ID: 4377761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on beta-adrenoceptor mediated facilitation of sympathetic neurotransmission.
    Dahlöf C
    Acta Physiol Scand Suppl; 1981; 500():1-147. PubMed ID: 6123220
    [No Abstract]   [Full Text] [Related]  

  • 25. Activation by nicotine of striatal neurons receiving excitatory input from the substantia nigra via dopamine release.
    Yu H; Matsubayashi H; Amano T; Cai J; Sasa M
    Brain Res; 2000 Jul; 872(1-2):223-6. PubMed ID: 10924698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of the immunoneutralization of substance P in the cat substantia nigra on the release of dopamine from dendrites and terminals of dopaminergic neurons.
    Cheramy A; Michelot R; Leviel V; Nieoullon A; Glowinski J; Kerdelhue B
    Brain Res; 1978 Oct; 155(2):404-8. PubMed ID: 688024
    [No Abstract]   [Full Text] [Related]  

  • 27. Non-dopaminergic nigrostriatal pathway.
    Guyenet PG; Crane JK
    Brain Res; 1981 Jun; 213(2):291-305. PubMed ID: 7248760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical and physiological studies of the beta-adrenoceptor and the D-2 dopamine receptor in the intermediate lobe of the rat pituitary gland: a review.
    Cote TE; Eskay RL; Frey EA; Grewe CW; Munemura M; Stoof JC; Tsuruta K; Kebabian JW
    Neuroendocrinology; 1982; 35(3):217-24. PubMed ID: 6290925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is the activity of kininase II (ACE; E.C. 3.4.15.1) influenced by beta-adrenergic factors?
    Melionis A; Davies JR; Jowett TP; Payne NN; Munday MR; Ma J; Vaughan NJ; Slater JD; Eisen V
    Adv Exp Med Biol; 1983; 156 (Pt B)():823-8. PubMed ID: 6305168
    [No Abstract]   [Full Text] [Related]  

  • 30. The susceptibility to acetylcholine and dopamine in the caudate nucleus of cats with chronic nigrostriatal lesions.
    Sphelmann R
    Trans Am Neurol Assoc; 1974; 99():255-7. PubMed ID: 4156892
    [No Abstract]   [Full Text] [Related]  

  • 31. Voltammetry in brain tissue: chronic recording of stimulated dopamine and 5-hydroxytryptamine release.
    Conti JC; Strope E; Adams RN; Marsden CA
    Life Sci; 1978 Dec; 23(27-28):2705-15. PubMed ID: 739848
    [No Abstract]   [Full Text] [Related]  

  • 32. [The role of nigroneostriatal dopamine in the transfer of corticofugal pulsation to caudal nuclei neurons in cats].
    Oleshko NN
    Dokl Akad Nauk SSSR; 1991; 320(4):1013-7. PubMed ID: 1786774
    [No Abstract]   [Full Text] [Related]  

  • 33. Taurine release from the pineal-gland is stimulated via a beta-adrenergic mechanism.
    Wheler GH; Klein DC
    Brain Res; 1980 Apr; 187(1):155-64. PubMed ID: 6244066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of muscarinic receptors in the rat caudate-putamen after lesioning of the ipsilateral nigrostriatal dopamine pathway with 6-hydroxydopamine (6-OHDA): normalization by fetal mesencephalic transplants.
    Dawson TM; Dawson VL; Gage FH; Fisher LJ; Hunt MA; Wamsley JK
    Brain Res; 1991 Feb; 540(1-2):145-52. PubMed ID: 1905173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Central cardiovascular effect of isoprenaline and some adrenergic beta blocking agents in neurogenic hypertensive dog: role of central beta-adrenoceptors (author's transl)].
    Montastruc P; Montastruc JL
    J Physiol (Paris); 1978; 74(7):651-8. PubMed ID: 218002
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies of the role of beta-adrenergic receptors in the activation of phosphorylase in rat hepatocytes by catecholamines.
    Cherrington AD; Hundley RF; Dolgin S; Exton JH
    J Cyclic Nucleotide Res; 1977 Aug; 3(4):263-73. PubMed ID: 199628
    [No Abstract]   [Full Text] [Related]  

  • 37. Reversible changes in the activities and amounts of tyrosine hydroxylase in dopamine neurons of the substantia nigra in response to axonal injury as studied by immunochemical and immunocytochemical methods.
    Reis DJ; Gilad G; Pickel VM; Joh TH
    Brain Res; 1978 Apr; 144(2):325-42. PubMed ID: 25123
    [No Abstract]   [Full Text] [Related]  

  • 38. Physiological regulation of beta-receptors in man.
    Wood AJ; Feldman R; Nadeau J
    Clin Exp Hypertens A; 1982; 4(4-5):807-17. PubMed ID: 6125283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of adrenergic receptors in the regulation of gastric motility in the rat.
    Gáti T; Gelencsér F; Hideg J
    Z Exp Chir; 1975; 8(3):179-84. PubMed ID: 44929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. beta-Adrenergic regulation of total systemic intravascular volume in the dog.
    Rutlen DL; Supple EN; Powell WJ
    Circ Res; 1981 Jan; 48(1):112-20. PubMed ID: 6254689
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.